Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032): a multicentre, open-label, two-stage, multi-arm, phase 1/2 trial Academic Article Article uri icon

Overview

MeSH Major

  • Antibodies, Anticardiolipin
  • Antiphospholipid Syndrome
  • beta 2-Glycoprotein I

abstract

  • Bristol-Myers Squibb.

publication date

  • November 2016

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1016/S1470-2045(16)30496-X

PubMed ID

  • 27733243

Additional Document Info

start page

  • 1590

end page

  • 1598

volume

  • 17

number

  • 11